Tushla Lara, Rudow Dianne LaPointe, Milton Jennifer, Rodrigue James R, Schold Jesse D, Hays Rebecca
University Transplant Program, Rush University Medical Center, Chicago, Illinois;
Recanati Miller Transplantation Institute, Mount Sinai Medical Center, New York, New York;
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1696-702. doi: 10.2215/CJN.01000115. Epub 2015 May 22.
Live-donor kidney transplantation (LDKT) is the best treatment for eligible people with late-stage kidney disease. Despite this, living kidney donation rates have declined in the United States in recent years. A potential source of this decline is the financial impact on potential and actual living kidney donors (LKDs). Recent evidence indicates that the economic climate may be associated with the decline in LDKT and that there are nontrivial financial ramifications for some LKDs. In June 2014, the American Society of Transplantation's Live Donor Community of Practice convened a Consensus Conference on Best Practices in Live Kidney Donation. The conference included transplant professionals, patients, and other key stakeholders (with the financial support of 10 other organizations) and sought to identify best practices, knowledge gaps, and opportunities pertaining to living kidney donation. This workgroup was tasked with exploring systemic and financial barriers to living kidney donation. The workgroup reviewed literature that assessed the financial effect of living kidney donation, analyzed employment and insurance factors, discussed international models for addressing direct and indirect costs faced by LKDs, and summarized current available resources. The workgroup developed the following series of recommendations to reduce financial and systemic barriers and achieve financial neutrality for LKDs: (1) allocate resources for standardized reimbursement of LKDs' lost wages and incidental costs; (2) pass legislation to offer employment and insurability protections to LKDs; (3) create an LKD financial toolkit to provide standardized, vetted education to donors and providers about options to maximize donor coverage and minimize financial effect within the current climate; and (4) promote further research to identify systemic barriers to living donation and LDKT to ensure the creation of mitigation strategies.
活体供肾移植(LDKT)是适合晚期肾病患者的最佳治疗方法。尽管如此,近年来美国活体肾捐赠率仍在下降。这种下降的一个潜在原因是对潜在和实际活体肾捐赠者(LKDs)的经济影响。最近的证据表明,经济环境可能与LDKT的下降有关,并且对一些LKDs存在重大的财务影响。2014年6月,美国移植学会的活体供体实践社区召开了一次关于活体肾捐赠最佳实践的共识会议。该会议包括移植专业人员、患者和其他关键利益相关者(在其他10个组织的财政支持下),旨在确定与活体肾捐赠相关的最佳实践、知识差距和机会。该工作组的任务是探索活体肾捐赠的系统性和财务障碍。该工作组审查了评估活体肾捐赠财务影响的文献,分析了就业和保险因素,讨论了应对LKDs面临的直接和间接成本的国际模式,并总结了当前可用资源。该工作组制定了以下一系列建议,以减少财务和系统性障碍,并实现LKDs的财务中立:(1)分配资源,对LKDs的工资损失和附带成本进行标准化补偿;(2)通过立法,为LKDs提供就业和可保险性保护;(3)创建一个LKD财务工具包,为捐赠者和提供者提供标准化、经过审查的教育,介绍在当前环境下最大化捐赠者覆盖范围和最小化财务影响的选项;(4)促进进一步研究,以确定活体捐赠和LDKT的系统性障碍,确保制定缓解策略。